CYTH

Cyclo Therapeutics (CYTH)

Cyclo Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CYTH

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/25	22 : 25	Business Wire	Cyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/06/15	05 : 01	GlobeNewswire Inc.	Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/05/30	22 : 00	Business Wire	Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/05/16	21 : 05	Business Wire	Cyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/03/18	22 : 05	Business Wire	Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/03/14	22 : 34	Business Wire	Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/03/14	06 : 04	GlobeNewswire Inc.	Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/03/05	06 : 33	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/02/16	06 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/02/16	06 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/02/16	06 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/02/16	06 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/02/16	06 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/02/16	06 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/02/16	06 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/02/15	04 : 44	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/01/29	23 : 15	Business Wire	Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/01/22	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CYTH	Cyclo Therapeutics Inc
2023/12/29	11 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2023/12/29	11 : 48	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2023/12/29	06 : 28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CYTH	Cyclo Therapeutics Inc
2023/12/28	10 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CYTH	Cyclo Therapeutics Inc
2023/12/28	06 : 15	Business Wire	Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.	NASDAQ:CYTH	Cyclo Therapeutics Inc
2023/12/27	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CYTH	Cyclo Therapeutics Inc
2023/12/18	23 : 15	Business Wire	Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1	NASDAQ:CYTH	Cyclo Therapeutics Inc
2023/12/18	20 : 02	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:CYTH	Cyclo Therapeutics Inc
2023/12/18	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CYTH	Cyclo Therapeutics Inc
2023/12/15	06 : 01	GlobeNewswire Inc.	Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results	NASDAQ:CYTH	Cyclo Therapeutics Inc
2023/12/01	06 : 30	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:CYTH	Cyclo Therapeutics Inc
2023/12/01	06 : 29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CYTH	Cyclo Therapeutics Inc